liu.seSearch for publications in DiVA
Endre søk
Begrens søket
1234567 51 - 100 of 654
RefereraExporteraLink til resultatlisten
Permanent link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Treff pr side
  • 5
  • 10
  • 20
  • 50
  • 100
  • 250
Sortering
  • Standard (Relevans)
  • Forfatter A-Ø
  • Forfatter Ø-A
  • Tittel A-Ø
  • Tittel Ø-A
  • Type publikasjon A-Ø
  • Type publikasjon Ø-A
  • Eldste først
  • Nyeste først
  • Skapad (Eldste først)
  • Skapad (Nyeste først)
  • Senast uppdaterad (Eldste først)
  • Senast uppdaterad (Nyeste først)
  • Disputationsdatum (tidligste først)
  • Disputationsdatum (siste først)
  • Standard (Relevans)
  • Forfatter A-Ø
  • Forfatter Ø-A
  • Tittel A-Ø
  • Tittel Ø-A
  • Type publikasjon A-Ø
  • Type publikasjon Ø-A
  • Eldste først
  • Nyeste først
  • Skapad (Eldste først)
  • Skapad (Nyeste først)
  • Senast uppdaterad (Eldste først)
  • Senast uppdaterad (Nyeste først)
  • Disputationsdatum (tidligste først)
  • Disputationsdatum (siste først)
Merk
Maxantalet träffar du kan exportera från sökgränssnittet är 250. Vid större uttag använd dig av utsökningar.
  • 51. Bobinski, L
    et al.
    Boström, Sverre
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Neurokirurgi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Neurokirurgiska kliniken US.
    Zsigmond, Peter
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Neurokirurgi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Neurokirurgiska kliniken US.
    Theodorsson, Annette
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för biomedicin och kirurgi, Avdelningen för klinisk kemi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Neurokirurgiska kliniken US.
    Leptomeningeal cyst due to vacuum extraction delivery in a twin infant2007Inngår i: Acta Neurochirurgica, ISSN 0001-6268, E-ISSN 0942-0940, Vol. 149, nr 3, s. 319-323Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    A rare case of a leptomeningeal cyst is reported in a twin male neonate delivered using a vacuum extractor, who presented a huge, non-pulsating, oedematous mass overlying the frontal fontanelle after birth. The mass was initially diagnosed as a cephalo haematoma. Ultrasonography indicated intracranial bleeding and a subsequent CT scan revealed an intraparenchymal bleeding above the left frontal horn, combined with a thin, left-sided, subdural haematoma and subarachnoid haemorrhage in the left Sylvian fissure. Apart from a bulging soft and round formation (2 × 2 × 3 cm) next to the anterior fontanel growing since birth, the neurological development of the infant was normal. MRI examination at the age of 7 months revealed that it consisted of a cystic mass (leptomeningeal cyst) connected to the left frontal horn, stretching right through the brain and also penetrating the dura mater. No signs of the perinatal haematomas were observed at this time. Surgical treatment, with fenestration of the cyst into the frontal horn and a watertight duraplasty with a periosteal flap and thrombin glue covered by small bone chips, was performed at 9 months of age. Due to a residual skull bone defect a second cranioplasty with autologous skull bone was performed three and half years later. During a follow-up period of 12 years the neurological and psychological development of the boy has been indistinguishable to that of his twin brother, indicating the satisfactory outcome of the treatment. © 2007 Springer-Verlag.

  • 52.
    Borch, Kurt
    et al.
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för biomedicin och kirurgi, Kirurgi. Östergötlands Läns Landsting, MKC-2, GE: Gastrokir.
    Jönsson, Björn
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för medicin och vård, Kärlkirurgi. Östergötlands Läns Landsting, Hjärtcentrum, Thorax-kärlkliniken.
    Tarpila, Erkki
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för biomedicin och kirurgi, Hand och plastikkirurgi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Hand- och plastikkirurgiska kliniken US.
    Franzén, Thomas
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för biomedicin och kirurgi, Kirurgi. Östergötlands Läns Landsting, MKC-2, GE: Gastrokir.
    Berglund, J
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för medicin och vård, Kärlkirurgi. Östergötlands Läns Landsting, Hjärtcentrum, Thorax-kärlkliniken.
    Kullman, Eric
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för biomedicin och kirurgi, Kirurgi. Östergötlands Läns Landsting, MKC-2, GE: Gastrokir.
    Franzén, L
    Changing pattern of histological type, location, stage and outcome of surgical treatment of gastric carcinoma2000Inngår i: British Journal of Surgery, ISSN 0007-1323, E-ISSN 1365-2168, Vol. 87, nr 5, s. 618-626Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Background: There are indications that some features of gastric carcinoma are changing, with a possible impact on prognosis. The aim of this study was to examine any changes in type, location, stage, resection rate, postoperative mortality rate or prognosis for patients with gastric carcinoma in a well defined population. Methods: During 1974-1991, 1161 new cases of gastric adenocarcinoma were diagnosed in Ostergotland County, Sweden. Tumour location, Lauren histological type, tumour node metastasis (TNM) stage, radicality of tumour resection and postoperative complications were recorded after histological re-evaluation of tissue specimens and examination of all patient records. Dates of death were obtained from the Swedish Central Bureau of Statistics. Time trends were studied by comparing the intervals 1974-1982 (period 1) and 1983-1991 (period 2). Results: The proportion of diffuse type of adenocarcinoma increased (from 27 to 35 per cent), while that of mixed type decreased (from 16 to 9 per cent) and that of intestinal type was unchanged. The proportion of tumours located in the proximal two-thirds of the stomach increased (from 32 to 42 per cent) and the proportion of patients with tumours in TNM stage IV decreased (from 32 to 25 per cent). Overall tumour resection rates were unchanged, although the proportion of radical total gastrectomies increased (from 36 to 50 per cent). Excluding tumours of the cardia or gastric remnant after previous ulcer surgery, the 5-year relative survival rate after radical resection increased from 25 to 36 per cent and the postoperative mortality rate decreased for both radical (from 11 to 4 per cent) and palliative (from 18 to 6 per cent) resection. Conclusion: The patterns of tumour histology, location and stage of gastric carcinoma have changed in the authors' region. These changes were paralleled by a significant improvement in survival and postoperative mortality rates.

  • 53.
    Borg, Jorgen
    et al.
    Karolinska Institute.
    Ward, Anthony B
    Haywood Hospital.
    Wissel, Joerg
    Kliniken Beelitz GmbH.
    Kulkarni, Jai
    Manchester Royal Infirmary.
    Sakel, Mohamed
    E Kent University Fdn Hospital Trust.
    Ertzgaard, Per
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Rehabiliteringsmedicin. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Rekonstruktionscentrum, Rehabiliteringsmedicinska kliniken US.
    Akerlund, Per
    Falu Lasarett.
    Reuter, Iris
    University Giessen.
    Herrmann, Christoph
    Asklepios Kliniken Schildautal.
    Satkunam, Lalith
    Glenrose Rehabil Hospital.
    Wein, Theodore
    Montreal General Hospital.
    Girod, Isabelle
    Allergan Ltd.
    Wright, Nicola
    Allergan Ltd.
    RATIONALE AND DESIGN OF A MULTICENTRE, DOUBLE-BLIND, PROSPECTIVE, RANDOMIZED, EUROPEAN AND CANADIAN STUDY: EVALUATING PATIENT OUTCOMES AND COSTS OF MANAGING ADULTS WITH POST-STROKE FOCAL SPASTICITY2011Inngår i: JOURNAL OF REHABILITATION MEDICINE, ISSN 1650-1977, Vol. 43, nr 1, s. 15-22Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Objective: This report describes the design of a study aiming to provide evidence for the extended use of botulinum toxin A (BOTOX(R), Allergan Inc.) in focal post-stroke upper and lower limb spasticity and to evaluate the impact of incorporating botulinum toxin A treatment into the rehabilitation of patients with spasticity. Design: International, prospective, randomized, double-blind, placebo-controlled study with an open-label extension. Methods: Approximately 300 adults with a stroke occurring 23 months before screening, presenting with symptoms and signs of an upper motor neuron syndrome and focal spasticity-related functional impairment, were randomized to botulinum toxin A+standard care or placebo+standard care. Study medication was administered at baseline and again at Week 12 if required, with follow-up to 52 weeks. The primary endpoint was the number of patients who achieved their investigator-rated principal active functional goal (as measured by Goal Attainment Scaling), at 10 weeks after the second injection (Weeks 22-34) or at the 24-week visit if no second injection was administered. Secondary endpoints included changes from baseline in level of goal achievement, health-related quality of life and resource utilization. Conclusion: The BOTOX(R) Economic Spasticity Trial (BEST) will provide information regarding clinical and cost-effectiveness of botulinum toxin+standard care vs standard care alone in patients with upper and/or lower limb post-stroke spasticity typically seen in clinical practice.

  • 54.
    Boström, Sverre
    et al.
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för klinisk och experimentell medicin, Neurokirurgi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Neurokirurgiska kliniken US.
    Bobinski, L
    Zsigmond, Peter
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för klinisk och experimentell medicin, Neurokirurgi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Neurokirurgiska kliniken US.
    Theodorsson, Annette
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för klinisk och experimentell medicin, Klinisk kemi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Neurokirurgiska kliniken US.
    Improved brain protection at decompressive craniectomy - a new method using Palacoso (R) R-40 (methylmethacrylate)2005Inngår i: Acta Neurochirurgica, ISSN 0001-6268, E-ISSN 0942-0940, Vol. 147, nr 3, s. 279-281Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    A new method is described for protecting the brain after decompressive craniectomy in which a temporary methylmethacrylate flap is formed, somewhat larger than the original bone flap, thus gaining "extra" volume for the oedematous brain in which to expand. The present procedure was developed as a pan of ordinary clinical practice particularly in response to demands from the NICU staff and our colleagues at other clinics who were responsible for the care of the patient in the post NICU period. They made us keenly aware that these patients frequently lack optimal co-ordination and balance and therefore run an increased risk of trauma to the unprotected brain when failing. This prompted us to develop a method for brain protection after decompressive craniectomy aiding in the care and rehabilitation until the final installation of the patient's own bone flap can be performed.

  • 55.
    Boström, Sverre
    et al.
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Neurokirurgi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Neurokirurgiska kliniken US.
    Bobinski, Lukas
    Zsigmond, Peter
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Neurokirurgi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Neurokirurgiska kliniken US.
    Nilsson, Inge
    Theodorsson, Annette
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för biomedicin och kirurgi, Avdelningen för klinisk kemi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Neurokirurgiska kliniken US.
    A new scaled microgauge for use in neurosurgery2005Inngår i: Acta Neurochirurgica, ISSN 0001-6268, E-ISSN 0942-0940, Vol. 147, nr 12, s. 1281-1282Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    A new scaled microgauge is described for measuring anatomical structures during microsurgery. The instrument has a tip marked in millimetres, which can be positioned in any desired angle enabling measurement in confined areas. © Springer-Verlag 2005.

  • 56.
    Bourghardt Peebo, Beatrice
    et al.
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Oftalmologi. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Rekonstruktionscentrum, Ögonkliniken US/LiM.
    Fagerholm, Per
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Oftalmologi. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Rekonstruktionscentrum, Ögonkliniken US/LiM.
    Lagali, Neil
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Oftalmologi. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Rekonstruktionscentrum, Ögonkliniken US/LiM.
    Transient Anterior Corneal Deposits in a Human Immunodeficiency Virus-Positive Patient2010Inngår i: CORNEA, ISSN 0277-3740, Vol. 29, nr 11, s. 1323-1327Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Purpose: To report findings of pigmented anterior corneal deposits in a human immunodeficiency virus-positive patient. Methods: Case report. A 49-year-old human immunodeficiency virus-positive patient was examined after the appearance of pigmented corneal deposits. Slit-lamp biomicroscopy, fundus photography, and laser-scanning in vivo confocal microscopy were performed to visually document the ocular condition. Results: The patient had a history of Mycobacterium avium infection and was suspected to have recovery uveitis from a cytomegalovirus infection. Small, rounded, light brown-colored deposits were distributed across the anterior cornea from limbus to limbus, bilaterally. In vivo confocal microscopy revealed the deposits to be confined to the basal epithelium and Bowman layer, whereas the posterior stroma, Descemet membrane, and the endothelium appeared normal. Systemic steroid treatment was administered, and 2 weeks later, the deposits had vanished on slit-lamp examination, whereas remnants were observed at the microscopic level. Conclusions: The deposits were unusual for their anterior corneal location and pancorneal distribution. The response to systemic steroid treatment remains unexplained and illustrates the complexity of the underlying conditions, their treatment, and the associated pathways of ocular manifestation.

  • 57.
    Bourghardt Peebo, Beatrice
    et al.
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Oftalmiatrik. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Rekonstruktionscentrum, Ögonkliniken US/LiM.
    Fagerholm, Per
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Oftalmiatrik. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Rekonstruktionscentrum, Ögonkliniken US/LiM.
    Traneus-Rockert, Catharina
    Östergötlands Läns Landsting, Laboratoriemedicinskt centrum, Klinisk patologi och klinisk genetik.
    Lagali, Neil
    Östergötlands Läns Landsting, Rekonstruktionscentrum, Ögonkliniken US/LiM. Linköpings universitet, Institutionen för klinisk och experimentell medicin, Oftalmiatrik. Linköpings universitet, Hälsouniversitetet.
    Cellular-Level Characterization of Lymph Vessels in Live, Unlabeled Corneas by In Vivo Confocal Microscopy2010Inngår i: Investigative Ophthalmology and Visual Science, ISSN 0146-0404, E-ISSN 1552-5783, Vol. 51, nr 2, s. 830-835Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    PURPOSE. To determine whether in vivo confocal microscopy (IVCM) of the cornea can be used for the label-free detection and monitoring of lymph vessels in live corneas.

    METHODS. Parallel corneal hemangiogenesis and lymphangiogenesis was induced by the placement of a single suture in one cornea of male Wistar rats. Fourteen days after suture placement and under general anesthesia, laser-scanning IVCM was performed in the vascularized region. Corneas were subsequently excised for flat-mount double immunofluorescence with a pan-endothelial marker (PECAM-1/CD31) and a lymphatic endothelial specific marker (LYVE-1). Using the suture area and prominent blood vessels as points of reference, the identical microscopic region was located in both fluorescent and archived in vivo images. Additionally, vessel diameter, lumen contrast, and cell diameter and velocity within vessels were quantified from in vivo images.

    RESULTS. Comparison of identical corneal regions in fluorescence and in vivo revealed prominent CD31(+)/LYVE-1(3+) lymph vessels that were visible in vivo. In vivo, corneal lymph vessels were located in the vascularized area in the same focal plane as blood vessels but had a darker lumen (P andlt; 0.001) sparsely populated by highly reflective cells with diameters similar to those of leukocytes in blood vessels (P = 0.61). Cell velocity in lymph vessels was significantly reduced compared with blood particle velocity (P andlt; 0.001). Morphologic characteristics enabled subsequent identification of corneal lymphatics in live, vascularized rat corneas before immunofluorescence labeling.

    CONCLUSIONS. IVCM enabled the nondestructive, label-free, in vivo detection of corneal lymphatics. IVCM provides the possibility of observing lymphatic activity in the same live corneas longitudinally and, as a clinical instrument, of monitoring corneal lymphatics in live human subjects.

  • 58.
    Bourghardt Peebo, Beatrice
    et al.
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Oftalmologi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Ögonkliniken US.
    Gan, Lisha
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Oftalmologi.
    Sun, Xiao-Feng
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för biomedicin och kirurgi, Onkologi. Östergötlands Läns Landsting, Kirurgi- och onkologicentrum, Onkologiska kliniken US.
    Knutsen Holmqvist, Annica
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för biomedicin och kirurgi, Onkologi. Östergötlands Läns Landsting, Kirurgi- och onkologicentrum, Onkologiska kliniken US.
    Rearden, Ann
    Fagerholm, Per
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Oftalmologi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Ögonkliniken US.
    Expression of the focal adhesion protein PINCH in normal and alkali-injured corneas and the role of PMNs2007Inngår i: Acta Ophthalmologica Scandinavica, ISSN 1395-3907, E-ISSN 1600-0420, Vol. 85, nr 4, s. 395-400Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Purpose: To evaluate the role of particularly interesting new cysteine-histidine-rich protein (PINCH) in corneal wound healing and early neovascularization and to assess the influence of granulocytes. Methods: A standardized corneal alkali wound was inflicted under general anaesthesia to the right eye of 14 New Zealand White rabbits. Seven of the rabbits received i.v. 5 mg/kg fucoidin every 2 hours to prevent granulocytes from entering the wound area. After 36 hours, the rabbits were killed, the corneas excised, fixed in 4% formaldehyde and embedded in paraffin. The sections were double-stained with antibodies against PINCH and with haematoxylin. Results: In the normal cornea and limbus, PINCH was weakly expressed in the corneal epithelium and in a wedge of the conjunctival stroma. In the wounded corneas, PINCH expression was seen in the frontline of repopulating endothelial and epithelial cells, and in active keratocytes. The vascular endothelium and the granulocytes expressed PINCH, as did the conjunctival epithelium. In the fucoidin-treated rabbits, PINCH expression was markedly reduced. The vascular endothelial cells and the few granulocytes did not express PINCH in these rabbits. Conclusions: PINCH is only slightly expressed in the normal cornea. A corneal wound induces PINCH expression in the repopulating cells, in the vascular endothelial cells of the limbus, in the limbal epithelium and in the granulocytes. Exclusion of granulocytes reduces expression of PINCH and there is no expression at all in the vascular endothelium. © 2007 The Authors Journal compilation 2007 Acta Ophthalmol Scand.

  • 59.
    Bourghardt Peebo, Beatrice
    et al.
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Oftalmologi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Ögonkliniken US.
    Koulikovska, Marina
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Oftalmologi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Ögonkliniken US.
    Fagerholm, Per
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Oftalmologi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Ögonkliniken US.
    The suppression of early angiogenic markers by the antiangiogenic aptamer Macugen R is dose dependent2007Inngår i: European Association for Vision and Eye Research,2007, 2007Konferansepaper (Annet vitenskapelig)
  • 60. Bourghardt Peebo, Beatrice
    et al.
    Peebo, Marcus
    Frennesson, Christina
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Oftalmologi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Ögonkliniken US.
    Relapsing polychondritis: A rare disease with varying symptoms2004Inngår i: Acta Ophthalmologica Scandinavica, ISSN 1395-3907, E-ISSN 1600-0420, Vol. 82, nr 4, s. 472-475Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Purpose: Relapsing polychondritis (RPC) is a rare systemic disease affecting primarily cartilaginous and proteoglycan-rich structures. It is a potentially fatal disease with unknown aetiology. There are no specific tests for RPC. The diagnosis is dependant on clinical criteria, which include chondritis of both auricles, non-erosive inflammatory polyarthritis, nasal chondritis, ocular inflammation, respiratory tract chondritis and cochlear and/or vestibular damage. Ocular symptoms will occur in approximately 60% of RPC patients. As an example, a patient with signs of RPC is described. Methods/Result: A 30-year-old woman was referred to our department for evaluation of a central corneal ulcer in the left eye. She had a history of recurrent pain in both her auricles and was also found to have a nasal septum perforation. Relapsing polychondritis was suspected. Conclusion: Non-healing corneal ulcers should alert the ophthalmologist to look for unusual reasons for this condition. RPC is one possible cause.

  • 61.
    Broström, Anders
    et al.
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för medicin och hälsa, Omvårdnad.
    Johansson, Peter
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för medicin och hälsa, Kardiologi. Östergötlands Läns Landsting, Hjärtcentrum, Kardiologiska kliniken.
    Albers, Jan
    City Hospital Ryhov.
    Wiberg, Jan
    City Hospital Ryhov.
    Svanborg, Eva
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för klinisk och experimentell medicin, Klinisk neurofysiologi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Neurofysiologiska kliniken US.
    Fridlund, Bengt
    Vaxjö University.
    6-month CPAP-treatment in a young male patient with severe obstructive sleep apnoea syndrome - A case study from the couples perspective2008Inngår i: European Journal of Cardiovascular Nursing, ISSN 1474-5151, E-ISSN 1873-1953, Vol. 7, nr 2, s. 103-112Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Background: Obstructive sleep apnoea syndrome (OSAS) is independently associated with an increased risk for hypertension and cardiovascular disease. Continuous positive airway pressure (CPAP) can reduce mortality and morbidity, but low compliance rates are seen. Aim: To explore and describe the experiences of CPAP-treatment in a young male patient with severe OSAS during a 6-month period from the couples perspective.

    Methods and the case: A single case study with a phenomenographic approach was employed. Diagnostic procedures of OSAS and initiation of treatment with Auto-CPAP, humidifier and a nasal mask were performed during 4 visits. Conceptions were collected at 4 different occasions during the 6-month period (before, and 2 weeks, 3 months, and 6 months after treatment initiation) by means of interviews with a 33-year old male patient and his female partner.

    Findings: Totally 17 different structural aspects were found to fluctuate during the 6-month period in relation to; influence of stressors, social reactions and adaptation to increase compliance.

    Conclusion: An increased knowledge about the influence of stressors, the social reactions, and the adaptation can help healthcare personnel to identify and better understand concerns of other patients and spouses during different time phases of the initial 6-month period of CPAP-treatment.

  • 62.
    Broström, Anders
    et al.
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för medicin och vård, Omvårdnad.
    Johansson, Peter
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för medicin och vård, Kardiologi. Östergötlands Läns Landsting, Hjärtcentrum, Kardiologiska kliniken.
    Albers, Jan
    Wiberg, Jan
    Svanborg, Eva
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Klinisk Neurofysiologi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Neurofysiologiska kliniken US.
    Fridlund, Bengt
    P374 3-Month CPAP treatment in a young male patient with severe obstructive sleep apnoea syndrome - a qualitative case study from the couple´s perspective2006Inngår i: 8th World Congress on Sleep Apnea 27-30 September 2006,2006, 2006, s. 76-76Konferansepaper (Annet vitenskapelig)
  • 63.
    Broström, Anders
    et al.
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Klinisk Neurofysiologi.
    Johansson, Peter
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för medicin och vård, Kardiologi. Östergötlands Läns Landsting, Hjärtcentrum, Kardiologiska kliniken.
    Kihl, J
    Forslund, P
    Dahlström, Ulf
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för medicin och vård, Kardiologi. Östergötlands Läns Landsting, Hjärtcentrum, Kardiologiska kliniken.
    Svanborg, Eva
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Klinisk Neurofysiologi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Neurofysiologiska kliniken US.
    Fridlund, B G
    Depressive symptoms in patients with chronic heart failure - effects on insomnia, daytime sleepiness and health-related quality of life2006Inngår i: World Congress of Cardiology,2006, 2006, s. 224-224Konferansepaper (Annet vitenskapelig)
  • 64.
    Broström, Anders
    et al.
    Linköpings universitet, Institutionen för medicin och hälsa, Omvårdnad. Linköpings universitet, Hälsouniversitetet.
    Johansson, Peter
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för medicin och vård, Kardiologi. Östergötlands Läns Landsting, Hjärtcentrum, Kardiologiska kliniken.
    Strömberg, Anna
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för medicin och vård, Omvårdnad.
    Albers, J
    County Hospital Ryhov.
    Mårtensson, Jan
    Linköpings universitet, Institutionen för medicin och hälsa, Omvårdnad. Linköpings universitet, Hälsouniversitetet.
    Svanborg, Eva
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Klinisk neurofysiologi. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Rekonstruktionscentrum, Neurofysiologiska kliniken US.
    Obstructive sleep apnoea syndrome - Patients' perceptions of their sleep and its effects on their life situation2007Inngår i: Journal of Advanced Nursing, ISSN 0309-2402, E-ISSN 1365-2648, Vol. 57, nr 3, s. 318-327Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Title. Obstructive sleep apnoea syndrome - patients' perceptions of their sleep and its effects on their life situation Aim. This paper reports a descriptive study of how untreated patients with obstructive sleep apnoea syndrome perceived their sleep situation and how the syndrome affected their life situation. Background. Obstructive sleep apnoea syndrome is a prevalent problem independently associated with an increased risk for hypertension, cardiovascular disease, chronic heart failure and mortality. Increased consumption of healthcare resources can often be seen among patients over a long period of time since many have been undiagnosed and untreated. Methods. A phenomenographic approach was employed. Data were collected by interviews during 2005 with 20 purposively selected participants with untreated obstructive sleep apnoea syndrome. Findings. Participants described loud snoring, frequent awakenings, dyspnoea, frustration over nocturia, fear of dying during sleep and partners' anxiety about the apnoea, as being night-time effects of obstructive sleep apnoea syndrome. They described dry and sore throats, tiredness and daytime sleepiness, shame about falling asleep and snoring, thoughts about complications and depressed mood as daytime effects. Needs, such as increased alertness, improved ability to concentrate, improved relationship, adequate information as well as effective treatment, were described. Participants tried self-care strategies such as information-seeking about sleep disturbances and treatment, adapted sleeping routines, change of bedroom arrangements, adapted daily schedules, hyperactivity and avoidance of difficult situations. Conclusion. The perceived effects and needs, as well as tried self-care actions by the patients with obstructive sleep apnoea syndrome in this study, could be used to identify and evaluate concerns of other patients with obstructive sleep apnoea syndrome waiting for treatment. © 2007 The Authors.

  • 65.
    Broström, Anders
    et al.
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för medicin och vård, Omvårdnad.
    Johansson, Peter
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för medicin och vård, Kardiologi. Östergötlands Läns Landsting, Hjärtcentrum, Kardiologiska kliniken.
    Strömberg, Anna
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för medicin och vård, Omvårdnad.
    Albers, Jan
    Wiberg, Jan
    Mårtensson, Jan
    Svanborg, Eva
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Klinisk Neurofysiologi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Neurofysiologiska kliniken US.
    Obstructive sleep apnea syndrome - Patient perceptions of their life situation before initiation of CPAP treatment2006Inngår i: 8th World Congress on Sleep Apnea 27-30 September, 2006,2006, 2006, s. 124-124Konferansepaper (Annet vitenskapelig)
  • 66.
    Broström, Anders
    et al.
    Linköpings universitet, Institutionen för medicin och hälsa, Omvårdnad. Linköpings universitet, Hälsouniversitetet.
    Nilsen, Per
    Linköpings universitet, Institutionen för medicin och hälsa, Socialmedicin och folkhälsovetenskap. Linköpings universitet, Hälsouniversitetet.
    Johansson, Peter
    Linköpings universitet, Institutionen för medicin och hälsa, Kardiologi. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Hjärtcentrum, Kardiologiska kliniken.
    Ulander, Martin
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Klinisk neurofysiologi. Linköpings universitet, Hälsouniversitetet.
    Strömberg, Anna
    Linköpings universitet, Institutionen för medicin och hälsa, Omvårdnad. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Hjärtcentrum, Kardiologiska kliniken.
    Svanborg, Eva
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Klinisk neurofysiologi. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Rekonstruktionscentrum, Neurofysiologiska kliniken US.
    Fridlund, Bengt
    Jonköping University.
    Putative facilitators and barriers for adherence to CPAP treatment in patients with obstructive sleep apnea syndrome: A qualitative content analysis2010Inngår i: SLEEP MEDICINE, ISSN 1389-9457, Vol. 11, nr 2, s. 126-130Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Introduction: Effective treatment of obstructive sleep apnea syndrome (OSAS) with continuous positive airway pressure (CPAP) can reduce morbidity and mortality, but adherence rates are low without a clear consensus Of causes. Objective: To explore the experiences of adherence to CPAP treatment in patients with OSAS. Methods: A qualitative content analysis was employed. Data were collected by in-depth interviews with 23 purposively selected patients. Results: Adherence to CPAP treatment was summarized according to "facilitators" and "barriers" to CPAP treatment. Facilitators for adherence, as described by the patients were a desire to avoid symptoms, knowledge about the risk for medical consequences, fear of negative social consequences and disturbing the sleep of significant others. Other facilitators were a positive attitude to CPAP treatment, trust in healthcare personnel, a sense of engagement from the spouse and a feeling of physical improvement. Barriers included experiencing practical problems, negative psychological effects of the equipment, and negative attitudes to the treatment. Other barriers were side-effects as well as insufficient support from healthcare personnel and the spouse. Conclusion: Adherence to CPAP treatment is a multifaceted problem including patient, treatment, condition, social and healthcare related factors. Knowledge about facilitators and barriers for adherence to CPAP treatment can be used in interventional Strategies.

  • 67.
    Broström, Anders
    et al.
    Linköpings universitet, Institutionen för medicin och hälsa, Avdelningen för omvårdnad. Linköpings universitet, Hälsouniversitetet.
    Strömberg, Anna
    Linköpings universitet, Institutionen för medicin och hälsa, Avdelningen för omvårdnad. Linköpings universitet, Hälsouniversitetet.
    Mårtensson, Jan
    Jönköping.
    Ulander, Martin
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Klinisk Neurofysiologi.
    Harder, Lena
    Svanborg, Eva
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Klinisk Neurofysiologi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Neurofysiologiska kliniken US.
    Association of Type D personality to perceived side effects and adherence in CPAP-treated patients with OSAS2007Inngår i: Journal of Sleep Research, ISSN 0962-1105, E-ISSN 1365-2869, Vol. 16, nr 4, s. 439-447Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Continuous positive airway pressure (CPAP) is the treatment of choice for obstructive sleep apnoea syndrome (OSAS), but side effects are common and long-term adherence low. The Type D (distressed) personality is defined as a combination of negative affectivity and social inhibition. The association of Type D personality with adherence has not been studied in CPAP-treated patients with OSAS. This study aimed to describe the prevalence of Type D personality in OSAS patients with CPAP treatment longer than 6 months and the association with self-reported side effects and adherence. A cross-sectional descriptive design was used. A total of 247 OSAS patients with a mean use of CPAP treatment for 55 months (6-182 months) were included. Data collection was achieved by two questionnaires, the Type D scale 14 (DS14) (Type D personality), SECI (side effects of CPAP), as well as from medical records (clinical variables and objective adherence to CPAP treatment). Type D personality occurred in 30% of the patients with OSAS and significantly (P < 0.05-0.001) increased the perceived frequency and severity of a broad range of side effects. The objective adherence was significantly lower (P < 0.001) for OSAS patients with Type D compared to OSAS patients without Type D, both with regard to a mean use of 4 h per night and 85% of the self-rated sleep time per night. The additional effect of a Type D personality on perceived side effects and adherence to CPAP treatment found in this study could be used by healthcare personnel when evaluating patients waiting for treatment. © 2007 European Sleep Research Society.

  • 68.
    Broström, Anders
    et al.
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Klinisk Neurofysiologi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Neurofysiologiska kliniken US.
    Strömberg, Anna
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för medicin och vård, Omvårdnad. Östergötlands Läns Landsting, Hjärtcentrum, Kardiologiska kliniken.
    Ulander, Martin
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Klinisk Neurofysiologi.
    Fridlund, B
    Mårtensson, J
    Svanborg, Eva
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Klinisk Neurofysiologi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Neurofysiologiska kliniken US.
    Informational needs, side effects and their consequences on adherence: A comparison between swedish healthcare professionals and CPAP-treated patients with obstructive sleep apnoea syndrome2007Inngår i: World Sleep 07,2007, 2007, s. 141-141Konferansepaper (Annet vitenskapelig)
    Abstract [en]

       

  • 69.
    Broström, Anders
    et al.
    Linköpings universitet, Institutionen för medicin och hälsa, Omvårdnad. Linköpings universitet, Hälsouniversitetet.
    Strömberg, Anna
    Linköpings universitet, Institutionen för medicin och hälsa, Omvårdnad. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Hjärtcentrum, Kardiologiska kliniken.
    Ulander, Martin
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Klinisk neurofysiologi. Linköpings universitet, Hälsouniversitetet.
    Fridlund, Bengt
    Vaxjö University.
    Martensson, Jan
    Jönköping University.
    Svanborg, Eva
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Klinisk neurofysiologi. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Rekonstruktionscentrum, Neurofysiologiska kliniken US.
    Perceived informational needs, side-effects and their consequences on adherence-A comparison between CPAP treated patients with OSAS and healthcare personnel2009Inngår i: Patient Education and Counseling, ISSN 0738-3991, E-ISSN 1873-5134, Vol. 74, nr 2, s. 228-235Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Objective: To compare perceptions among continuous positive airway pressure (CPAP) treated patients with obstructive sleep apnoea syndrome (OSAS) and healthcare personnel with regard to informational needs, side-effects and their consequences on adherence.

    Methods: A cross-sectional descriptive design was used including 350 CPAP treated OSAS patients from three Swedish hospitals and 105 healthcare personnel from 26 Swedish hospitals. Data collection was performed using two questionnaires covering informational needs, side-effects and adherence to CPAP.

    Results: Both groups perceived all surveyed informational areas as very important. Patients perceived the possibilities to learn as significantly greater in all areas (p < 0.001) compared to healthcare personnel, and scored significantly higher regarding positive effects on adherence of information about pathophysiology (p < 0.05), self-care (p < 0.001) and troubleshooting (p < 0.01). A total of I I out of 15 surveyed side-effects were perceived to be more frequent by healthcare personnel (p < 0.01 - p < 0.001). They also scored all side-effects to cause greater problems and decrease the CPAP use to a greater extent (p < 0.001).

    Conclusion: Knowledge about these differences between patients and healthcare personnel regarding educational needs, side-effects and their effects on adherence can be important when designing educational programmes to increase CPAP adherence.

    Practice implications: Measurement of these parameters before, during and after educational programs are suggested.

  • 70.
    Broström, Anders
    et al.
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Neurofysiologi.
    Strömberg, Anna
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för medicin och vård, Omvårdnad. Östergötlands Läns Landsting, Hjärtcentrum, Kardiologiska kliniken.
    Ulander, Martin
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Klinisk Neurofysiologi.
    Mårtensson, J
    Svanborg, Eva
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Klinisk Neurofysiologi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Neurofysiologiska kliniken US.
    Association of type D personality to perceived side effects and adherence in CPAP-treated patients with obstructive sleep apnoea syndrome2007Inngår i: World Sleep 07,2007, 2007, s. 142-142Konferansepaper (Annet vitenskapelig)
    Abstract [en]

      

  • 71.
    Bruder, CEG
    et al.
    Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria Lab Mol Pathol, BG-1431 Sofia, Bulgaria Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland House Ear Inst, Los Angeles, CA 90057 USA Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA.
    Hirvela, C
    Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria Lab Mol Pathol, BG-1431 Sofia, Bulgaria Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland House Ear Inst, Los Angeles, CA 90057 USA Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA.
    Tapia-Paez, I
    Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria Lab Mol Pathol, BG-1431 Sofia, Bulgaria Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland House Ear Inst, Los Angeles, CA 90057 USA Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA.
    Fransson, I
    Segraves, R
    Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria Lab Mol Pathol, BG-1431 Sofia, Bulgaria Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland House Ear Inst, Los Angeles, CA 90057 USA Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA.
    Hamilton, G
    Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria Lab Mol Pathol, BG-1431 Sofia, Bulgaria Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland House Ear Inst, Los Angeles, CA 90057 USA Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA.
    Zhang, XX
    Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria Lab Mol Pathol, BG-1431 Sofia, Bulgaria Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland House Ear Inst, Los Angeles, CA 90057 USA Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA.
    Evans, DG
    Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria Lab Mol Pathol, BG-1431 Sofia, Bulgaria Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland House Ear Inst, Los Angeles, CA 90057 USA Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA.
    Wallace, AJ
    Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria Lab Mol Pathol, BG-1431 Sofia, Bulgaria Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland House Ear Inst, Los Angeles, CA 90057 USA Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA.
    Baser, ME
    Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria Lab Mol Pathol, BG-1431 Sofia, Bulgaria Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland House Ear Inst, Los Angeles, CA 90057 USA Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA.
    Zucman-Rossi, J
    Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria Lab Mol Pathol, BG-1431 Sofia, Bulgaria Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland House Ear Inst, Los Angeles, CA 90057 USA Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA.
    Hergersberg, M
    Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria Lab Mol Pathol, BG-1431 Sofia, Bulgaria Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland House Ear Inst, Los Angeles, CA 90057 USA Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA.
    Boltshauser, E
    Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria Lab Mol Pathol, BG-1431 Sofia, Bulgaria Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland House Ear Inst, Los Angeles, CA 90057 USA Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA.
    Papi, L
    Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria Lab Mol Pathol, BG-1431 Sofia, Bulgaria Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland House Ear Inst, Los Angeles, CA 90057 USA Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA.
    Rouleau, GA
    Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria Lab Mol Pathol, BG-1431 Sofia, Bulgaria Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland House Ear Inst, Los Angeles, CA 90057 USA Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA.
    Poptodorov, G
    Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria Lab Mol Pathol, BG-1431 Sofia, Bulgaria Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland House Ear Inst, Los Angeles, CA 90057 USA Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA.
    Jordanova, A
    Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria Lab Mol Pathol, BG-1431 Sofia, Bulgaria Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland House Ear Inst, Los Angeles, CA 90057 USA Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA.
    Rask-Andersen, H
    Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria Lab Mol Pathol, BG-1431 Sofia, Bulgaria Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland House Ear Inst, Los Angeles, CA 90057 USA Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA.
    Kluwe, L
    Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria Lab Mol Pathol, BG-1431 Sofia, Bulgaria Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland House Ear Inst, Los Angeles, CA 90057 USA Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA.
    Mautner, V
    Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria Lab Mol Pathol, BG-1431 Sofia, Bulgaria Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland House Ear Inst, Los Angeles, CA 90057 USA Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA.
    Sainio, M
    Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria Lab Mol Pathol, BG-1431 Sofia, Bulgaria Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland House Ear Inst, Los Angeles, CA 90057 USA Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA.
    Hung, G
    Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria Lab Mol Pathol, BG-1431 Sofia, Bulgaria Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland House Ear Inst, Los Angeles, CA 90057 USA Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA.
    Mathiesen, T
    Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria Lab Mol Pathol, BG-1431 Sofia, Bulgaria Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland House Ear Inst, Los Angeles, CA 90057 USA Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA.
    Moller, C
    Pulst, SM
    Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria Lab Mol Pathol, BG-1431 Sofia, Bulgaria Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland House Ear Inst, Los Angeles, CA 90057 USA Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA.
    Harder, Henrik
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för klinisk och experimentell medicin, Oto-Rhino-Laryngologi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Öronkliniken US.
    Heiberg, A
    Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria Lab Mol Pathol, BG-1431 Sofia, Bulgaria Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland House Ear Inst, Los Angeles, CA 90057 USA Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA.
    Honda, M
    Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria Lab Mol Pathol, BG-1431 Sofia, Bulgaria Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland House Ear Inst, Los Angeles, CA 90057 USA Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA.
    Miimura, M
    Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria Lab Mol Pathol, BG-1431 Sofia, Bulgaria Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland House Ear Inst, Los Angeles, CA 90057 USA Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA.
    Sahlen, S
    Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria Lab Mol Pathol, BG-1431 Sofia, Bulgaria Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland House Ear Inst, Los Angeles, CA 90057 USA Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA.
    Blennow, E
    Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria Lab Mol Pathol, BG-1431 Sofia, Bulgaria Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland House Ear Inst, Los Angeles, CA 90057 USA Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA.
    Albertson, DG
    Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria Lab Mol Pathol, BG-1431 Sofia, Bulgaria Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland House Ear Inst, Los Angeles, CA 90057 USA Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA.
    Pinkel, D
    Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria Lab Mol Pathol, BG-1431 Sofia, Bulgaria Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland House Ear Inst, Los Angeles, CA 90057 USA Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA.
    Dumanski, JP
    Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria Lab Mol Pathol, BG-1431 Sofia, Bulgaria Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland House Ear Inst, Los Angeles, CA 90057 USA Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA.
    High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH2001Inngår i: Human Molecular Genetics, ISSN 0964-6906, E-ISSN 1460-2083, Vol. 10, nr 3, s. 271-282Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Neurofibromatosis type 2 (NF2) is an autosomal dominant disorder whose hallmark is bilateral vestibular schwannoma. It displays a pronounced clinical heterogeneity with mild to severe forms. The NF2 tumor suppressor (merlin/schwannomin) has been cloned and extensively analyzed for mutations in patients with different clinical variants of the disease. Correlation between the type of the NF2 gene mutation and the patient phenotype has been suggested to exist. However, several independent studies have shown that a fraction of NF2 patients with various phenotypes have constitutional deletions that partly or entirely remove one copy of the NF2 gene. The purpose of this study was to examine a 7 Mb interval in the vicinity of the NF2 gene in a large series of NF2 patients in order to determine the frequency and extent of deletions. A total of 116 NF2 patients were analyzed using high-resolution array-comparative genomic hybridization (CGH) on an array covering at least 90% of this region of 22q around the NF2 locus. Deletions, which remove one copy of the entire gene or are predicted to truncate the schwannomin protein, were detected in 8 severe, 10 moderate and 6 mild patients. This result does not support the correlation between the type of mutation affecting the NF2 gene and the disease phenotype. This work also demonstrates the general usefulness of the array-CON methodology for rapid and comprehensive detection of small (down to 40 kb) heterozygous and/or homozygous deletions occurring in constitutional or tumor-derived DNA.

  • 72. Bäckman, C
    et al.
    Orwelius, Lotti
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för medicin och vård, Omvårdnad.
    Sjöberg, Folke
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för biomedicin och kirurgi, Avdelningen för kirurgi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Hand- och plastikkirurgiska kliniken US.
    Nordlund, P
    Simonsson, E
    Walther, Sten
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för medicin och vård, Fysiologi. Östergötlands Läns Landsting, Hjärtcentrum, Thorax-kärlkliniken.
    Do ICU-diaries influence health related quality of life after critical illness?2007Inngår i: in Intensive Care Medicine(ISSN 0342-4642), vol 33, 2007, Vol. 33, s. 13-13Konferansepaper (Fagfellevurdert)
  • 73.
    Caceres, R.
    et al.
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Neurologi. Linköpings universitet, Hälsouniversitetet.
    Richter, J.
    Östergötlands Läns Landsting, Rekonstruktionscentrum, Neurokirurgiska kliniken US.
    Säfström, Kåge
    Linköpings universitet, Institutionen för medicin och hälsa, Kardiologi. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Hjärtcentrum, Kardiologiska kliniken.
    Landtblom, Anne-Marie
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Neurologi. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Närsjukvården i centrala Östergötland, Neurologiska kliniken. Östergötlands Läns Landsting, Närsjukvården i västra Östergötland, Medicinska specialistkliniken .
    Editorial: Application of a vagal nerve stimulator in an epilepsy patient with cardiac pacemaker after post-ictal cardiac arrest2009Inngår i: Acta Neurologica Scandinavica, ISSN 0001-6314, E-ISSN 1600-0404, Vol. 120, nr 2, s. 139-142Artikkel i tidsskrift (Annet vitenskapelig)
    Abstract [en]

    In this case report we present a patient with temporal lobe epilepsy (TLE) showing partial complex seizures and secondary generalization, and treated with several antiepileptic drugs. After two consecutive seizures she had an episode of cardiac arrest followed by AV-block III which led to the implantation of a cardiac pacemaker. She subsequently received a vagal nerve stimulator because of poor response to epilepsy treatment. Combined treatment with two different electromagnetic stimulators raises the question of safety during surgery which is discussed.

  • 74.
    Carlstedt, Thomas
    et al.
    Royal National Orthopaedic Hospital.
    Hultgren, Tomas
    Karolinska Institute.
    Nyman, Torbjörn
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Hand och plastikkirurgi. Linköpings universitet, Hälsouniversitetet.
    Hansson, Thomas
    Linköpings universitet, Institutionen för biomedicin och kirurgi, Avdelningen för kirurgi. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Rekonstruktionscentrum, Hand- och plastikkirurgiska kliniken US.
    Cortical activity and hand function restoration in a patient after spinal cord surgery2009Inngår i: NATURE REVIEWS NEUROLOGY, ISSN 1759-4758, Vol. 5, nr 10, s. 571-574Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Background. Following a motorcycle accident, a 9-year-old boy experienced a complete right-sided ( dominant) arm and hand paralysis with total sensory loss, Horner syndrome and severe constant pain. This study assessed the long-term outcome of spinal cord surgery undertaken on the patient, focusing on the restored hand function and related cortical activity. The study follows on from previous reports on the same patient. Investigations. Clinical functional and electrophysiological examinations. Functional MRI of cortical activity. Diagnosis. Complete brachial plexus (C5-T1) avulsion from the spinal cord. Management. Spinal cord surgery to restore motor trajectories.

  • 75.
    Chatzikokkinou, P.
    et al.
    Department of Dermatology and Venereology, University of Trieste, Ospedale Maggiore, Via Stuparich 1, I-34100 Trieste, Italy.
    Thorfinn, Johan
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Kirurgi. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Rekonstruktionscentrum, Hand- och plastikkirurgiska kliniken US.
    Angelidis, I.K.
    Division of Plastic and Reconstructive Surgery, Stanford University Medical Center, 770 Welch Road, Palo Alto, CA 94305, United States.
    Papa, G.
    University Department of Plastic and Reconstructive Surgery, University of Trieste, Cattinara Hospital Trieste, Strada di Fiume 447, I-34100 Trieste, Italy.
    Trevisan, G.
    Department of Dermatology and Venereology, University of Trieste, Ospedale Maggiore, Via Stuparich 1, I-34100 Trieste, Italy.
    Spontaneous endometriosis in an umbilical skin lesion2009Inngår i: Acta Dermatovenerologica Alpina, Pannonica et Adriatica, ISSN 1318-4458, Vol. 18, nr 3, s. 126-130Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Cutaneous endometriosis of the umbilicus is an unusual condition with unclear pathogenetic mechanisms that might be mistaken for a malignant condition. A 46-year-old woman presented with a cutaneous black mass in the umbilicus. The lesion was removed surgically and histological analyses revealed that it consisted of endometrial tissue. There was no recurrence at 18-month follow-up. Endometriosis of the umbilicus is a rare condition and the pathogenesis is not completely elucidated. According to one theory, intraperitoneal endometrial tissue is translocated during endoscopic surgery or other surgical procedures that involve the umbilicus. However, in this case there was no history of abdominal wall surgery. We conclude that endometriosis is important to consider in cases of unclear skin lesions of the umbilicus, even in cases with no previous abdominal surgery. Moreover, umbilical endometriosis of the skin can have different appearances that resemble malignant tumors, and radical surgery with histology is therefore indicated.

  • 76. Chong, Victor N H
    et al.
    Keonin, Jason
    Luthert, Phil J
    Frennesson, Christina
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Oftalmologi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Ögonkliniken US.
    Weingeist, David M
    Wolf, Rachel L
    Mullins, Robert F
    Hageman, Gregory S
    Decreased thickness and integrity of the macular elastic layer of Bruch's membrane correspond to the distribution of lesions associated with age-related macular degeneration2005Inngår i: American Journal of Pathology, ISSN 0002-9440, E-ISSN 1525-2191, Vol. 166, nr 1, s. 241-251Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Age-related macular degeneration (AMD) is a leading cause of blindness in the elderly. In its severest form, choroidal neovessels breach the macular Bruch's membrane, an extracellular matrix compartment comprised of elastin and collagen laminae, and grow into the retina. We sought to determine whether structural properties of the elastic lamina (EL) correspond to the region of the macula that is predilected toward degeneration in AMD. Morphometric assessment of the macular and extramacular regions of 121 human donor eyes, with and without AMD, revealed a statistically significant difference in both the integrity (P < 0.0001) and thickness (P < 0.0001) of the EL between the macular and extramacular regions in donors of all ages. The EL was three to six times thinner and two to five times less abundant in the macula than in the periphery. The integrity of the macular EL was significantly lower in donors with early-stage AMD (P = 0.028), active choroidal neovascularization (P = 0.020), and disciform scars (P = 0.003), as compared to unaffected, age-matched controls. EL thickness was significantly lower only in individuals with disciform scars (P = 0.008). The largest gaps in macular EL integrity were significantly larger in all categories of AMD (each P < 0.0001), as compared to controls. EL integrity, thickness, and gap length in donors with geographic atrophy did not differ from those of controls. These structural properties of the macular EL correspond spatially to the distribution of macular lesions associated with AMD and may help to explain why the macula is more susceptible to degenerative events that occur in this disease.

  • 77. Claesson, M
    et al.
    Armitage, W J
    Fagerholm, Per
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Oftalmologi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Ögonkliniken US/LiM.
    Stenevi, U
    Visual outcome in corneal grafts: a preliminary analysis of the Swedish Corneal Transplant Register2002Inngår i: British Journal of Ophthalmology, ISSN 0007-1161, E-ISSN 1468-2079, Vol. 86, s. 174-180Artikkel i tidsskrift (Fagfellevurdert)
  • 78. Clarkson, James
    et al.
    Probst, Fey
    Niranjan, Niri
    Meuli, Claudia
    Vogt, Paul
    Lidman, Disa
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för biomedicin och kirurgi, Hand och plastikkirurgi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Hand- och plastikkirurgiska kliniken US.
    Andersson, Lena
    Our experience using the vertical rectus abdominis muscle flap for reconstruction in 12 patients with dehiscence of a median sternotomy wound and mediastinitis2003Inngår i: Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery, ISSN 2000-656X, E-ISSN 2000-6764, Vol. 37, nr 5, s. 266-271Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    The vertical rectus abdominis (VRAM) flap has been used for reconstruction of sternal defects, particularly in the interior third, since it was first described 20 years ago. We describe 12 patients with mediastinitis or chronic sternal osteomyelitis after sternotomy treated between 1994 and 1997, nine performed at the Royal Hospitals Trust, London. Sternal osteomyelitis and mediastinitis after median sternotomy is an uncommon (0.4%-8.4%) but often fatal condition. Vascularised pedicles are the treatment of choice, and VRAM flaps were used in all cases. We report good long-term outcome with a follow up of 2-5 years, and no long-term morbidity relating to the VRAM reconstruction. We had only one partial failure of a flap. The operations were largely done in hospitals away from the plastic surgical unit in extremely sick patients, which illustrates the importance of multidisciplinary management to reduce hospital stay, mortality, and morbidity. We argue that early involvement of plastic surgical specialists in the treatment of sternal dehiscence is essential to ensure a successful outcome.

  • 79.
    Cohn-Cedermark, G
    et al.
    Karolinska Hosp, Radiumhemmet, Dept Oncol Pathol, S-17176 Stockholm, Sweden Karolinska Hosp, Ctr Oncol, Dept Oncol Pathol, S-10401 Stockholm, Sweden Univ Umea Hosp, Dept Radiat Sci, S-90185 Umea, Sweden Orebro Reg Hosp, Dept Oncol, Orebro, Sweden Univ Lund Hosp, Dept Surg, S-22185 Lund, Sweden Helsingborg Hosp, Dept Surg, Helsingborg, Sweden Linkoping Univ Hosp, Dept Hand Surg Plast Surg & Burns, S-58185 Linkoping, Sweden Ryhov Cty Hosp, Dept Oncol, Jonkoping, Sweden.
    Rutqvist, LE
    Karolinska Hosp, Radiumhemmet, Dept Oncol Pathol, S-17176 Stockholm, Sweden Karolinska Hosp, Ctr Oncol, Dept Oncol Pathol, S-10401 Stockholm, Sweden Univ Umea Hosp, Dept Radiat Sci, S-90185 Umea, Sweden Orebro Reg Hosp, Dept Oncol, Orebro, Sweden Univ Lund Hosp, Dept Surg, S-22185 Lund, Sweden Helsingborg Hosp, Dept Surg, Helsingborg, Sweden Linkoping Univ Hosp, Dept Hand Surg Plast Surg & Burns, S-58185 Linkoping, Sweden Ryhov Cty Hosp, Dept Oncol, Jonkoping, Sweden.
    Andersson, R
    Breivald, M
    Karolinska Hosp, Radiumhemmet, Dept Oncol Pathol, S-17176 Stockholm, Sweden Karolinska Hosp, Ctr Oncol, Dept Oncol Pathol, S-10401 Stockholm, Sweden Univ Umea Hosp, Dept Radiat Sci, S-90185 Umea, Sweden Orebro Reg Hosp, Dept Oncol, Orebro, Sweden Univ Lund Hosp, Dept Surg, S-22185 Lund, Sweden Helsingborg Hosp, Dept Surg, Helsingborg, Sweden Linkoping Univ Hosp, Dept Hand Surg Plast Surg & Burns, S-58185 Linkoping, Sweden Ryhov Cty Hosp, Dept Oncol, Jonkoping, Sweden.
    Ingvar, C
    Karolinska Hosp, Radiumhemmet, Dept Oncol Pathol, S-17176 Stockholm, Sweden Karolinska Hosp, Ctr Oncol, Dept Oncol Pathol, S-10401 Stockholm, Sweden Univ Umea Hosp, Dept Radiat Sci, S-90185 Umea, Sweden Orebro Reg Hosp, Dept Oncol, Orebro, Sweden Univ Lund Hosp, Dept Surg, S-22185 Lund, Sweden Helsingborg Hosp, Dept Surg, Helsingborg, Sweden Linkoping Univ Hosp, Dept Hand Surg Plast Surg & Burns, S-58185 Linkoping, Sweden Ryhov Cty Hosp, Dept Oncol, Jonkoping, Sweden.
    Johansson, H
    Jonsson, PE
    Krysander, Lennart
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för klinisk och experimentell medicin, Kirurgi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Hand- och plastikkirurgiska kliniken US.
    Lindholm, C
    Ringborg, U
    Karolinska Hosp, Radiumhemmet, Dept Oncol Pathol, S-17176 Stockholm, Sweden Karolinska Hosp, Ctr Oncol, Dept Oncol Pathol, S-10401 Stockholm, Sweden Univ Umea Hosp, Dept Radiat Sci, S-90185 Umea, Sweden Orebro Reg Hosp, Dept Oncol, Orebro, Sweden Univ Lund Hosp, Dept Surg, S-22185 Lund, Sweden Helsingborg Hosp, Dept Surg, Helsingborg, Sweden Linkoping Univ Hosp, Dept Hand Surg Plast Surg & Burns, S-58185 Linkoping, Sweden Ryhov Cty Hosp, Dept Oncol, Jonkoping, Sweden.
    Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm2000Inngår i: Cancer, ISSN 0008-543X, E-ISSN 1097-0142, Vol. 89, nr 7, s. 1495-1501Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    BACKGROUND. Large, prospective, randomized trials with long term follow-up are required to obtain an unbiased evaluation of the significance of resection margins in patients with cutaneous melanoma. METHODS, The Swedish Melanoma Study Group performed a prospective, randomized, multicenter study of patients with primary melanoma located on trunk or extremities and with a tumor thickness > 0.8 mm and less than or equal to 2 mm. Patients were allocated randomly to a 2-cm excision margin or a 5-cm excision margin. In total, 989 patients were recruited during the period 1982-1991. The median follow-up, was 11 years (range, 7-17 years) for estimation of survival and 8 years (range, 0-17 years) for evaluation of recurrent disease. RESULTS. The crude rate of local recurrence, defined as a recurrence in the scar or transplant, was < 1% (8 of 989 patients). Twenty percent of the patients (194 of 989 patients) experienced any disease recurrence, and 15% (146 of 989 patients) died of melanoma. There were no statistically significant differences between the two treatment arms. In a multivariate Cox analysis with patients allocated to wide excision as the reference group, the estimated relative hazards for overall survival and recurrence free survival among those allocated to a 2-cm resection margin were 0.96 (95% confidence interval, 0.75-1.24), and 1.02 (95% confidence interval, 0.80-1.30), respectively. CONCLUSIONS. In this long term follow-up study, local recurrences were found to be rare among patients with tumors > 0.8 mm thick and less than or equal to 2.0 mm thick. Mo difference in recurrence rate or survival between the two treatment groups was found. Patients in this category can be treated with a resection margin of 2 cm as safely as with a resection margin of 5 cm. Cancer 2000,89:1495-501. (C) 2000 American Cancer Society.

  • 80.
    Crafoord, Sven
    et al.
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för klinisk och experimentell medicin, Oftalmologi.
    Algvere, Peep
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för klinisk och experimentell medicin, Oftalmologi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Ögonkliniken US/LiM.
    Seregard, S
    Orebro Med Ctr Hosp, Dept Ophthalmol, S-70185 Orebro, Sweden St Eriks Eye Hosp, Karolinska Inst, Stockholm, Sweden Linkoping Univ, Dept Ophthalmol, Linkoping, Sweden.
    Dafgard-Kopp, E
    Orebro Med Ctr Hosp, Dept Ophthalmol, S-70185 Orebro, Sweden St Eriks Eye Hosp, Karolinska Inst, Stockholm, Sweden Linkoping Univ, Dept Ophthalmol, Linkoping, Sweden.
    Cellular migration into neural retina following implantation of melanin granules to the subretinal space.2000Inngår i: Investigative Ophthalmology and Visual Science, ISSN 0146-0404, E-ISSN 1552-5783, Vol. 41, nr 4, s. 4545B492-Konferansepaper (Annet vitenskapelig)
  • 81.
    Crafoord, Sven
    et al.
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Oftalmologi.
    Geng, Lijun
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Oftalmologi.
    Seregard, Stefan
    Algvere, Peep
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Oftalmologi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Ögonkliniken US/LiM.
    Experimental transplantation of autologous iris pigment epithelial cells to the subretinal space2001Inngår i: Acta Ophthalmologica Scandinavica, ISSN 1395-3907, E-ISSN 1600-0420, Vol. 79, nr 5, s. 509-514Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Purpose: To investigate the cellular morphology in the subretinal space following transplantation of iris pigment epithelial (IPE) cells from the same eye. Methods: Following an iridectomy, fresh IPE cells were prepared and no culturing performed. After pars plana vitrectomy, a suspension of autologous IPE cells was injected into the subretinal space in 37 rabbits. The grafts were monitored by ophthalmoscopy and colour fundus photography. Rabbits were sacrificed at 1, 2, 3 and 6 months, respectively, and the eyes examined with light and electron microscopy. Results: The grafted area retained the same configuration over 6 months but then appeared less pigmented. At 1-3 months, the IPE formed one or more contiguous layers on top of native RPE. At 6 months, cells compatible with grafted IPE were present in the subretinal space, often forming monolayer-like chains integrating with the native RPE. Depigmented cells of presumed IPE origin were seen and frequently in association with abundant melanin granules located in the apical portion of adjacent RPE cells. In such areas, large macrophage-like cells were observed. Conclusion: Transplanted IPE cells survived for up to 6 months in the subretinal space. Our observations suggest a scenario of remodelling of the cellular layers in the subretinal space over time where grafted IPE cells formed a compound layer with the native RPE. Transplantation of autologous IPE cells may have a potential as a treatment modality in selected cases of age-related macular degeneration.

  • 82.
    Dahlman, Joakim
    et al.
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Rehabiliteringsmedicin. Linköpings universitet, Hälsouniversitetet.
    Sjörs, Anna
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Rehabiliteringsmedicin. Linköpings universitet, Hälsouniversitetet.
    Ledin, Torbjörn
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Oto-Rhino-Laryngologi. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Rekonstruktionscentrum, Öronkliniken US.
    Falkmer, Torbjörn
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Rehabiliteringsmedicin. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Närsjukvården i centrala Östergötland, Habiliteringen: Barn- och ungdomshabiliteringen, LSS Råd och stöd.
    Could sound be used as a strategy for reducing symptoms of perceived motion sickness?2008Inngår i: Journal of NeuroEngineering and Rehabilitation, ISSN 1743-0003, E-ISSN 1743-0003, Vol. 5, nr 35Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Background: Working while exposed to motions, physically and psychologically affects a person. Traditionally, motion sickness symptom reduction has implied use of medication, which can lead to detrimental effects on performance. Non-pharmaceutical strategies, in turn, often require cognitive and perceptual attention. Hence, for people working in high demand environments where it is impossible to reallocate focus of attention, other strategies are called upon. The aim of the study was to investigate possible impact of a mitigation strategy on perceived motion sickness and psychophysiological responses, based on an artificial sound horizon compared with a non-positioned sound source.

    Method: Twenty-three healthy subjects were seated on a motion platform in an artificial sound horizon or in non-positioned sound, in random order with one week interval between the trials. Perceived motion sickness (Mal), maximum duration of exposure (ST), skin conductance, blood volume pulse, temperature, respiration rate, eye movements and heart rate were measured continuously throughout the trials.

    Results: Mal scores increased over time in both sound conditions, but the artificial sound horizon, applied as a mitigation strategy for perceived motion sickness, showed no significant effect on Mal scores or ST. The number of fixations increased with time in the non-positioned sound condition. Moreover, fixation time was longer in the nonpositioned sound condition compared with sound horizon, indicating that the subjects used more time to fixate and, hence, assumingly made fewer saccades.

    Conclusion: A subliminally presented artificial sound horizon did not significantly affect perceived motion sickness, psychophysiological variables or the time the subjects endured the motion sickness triggering stimuli. The number of fixations and fixation times increased over time in the non-positioned sound condition.

  • 83.
    Dahlman, Joakim
    et al.
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Rehabiliteringsmedicin. Linköpings universitet, Hälsouniversitetet.
    Sjörs, Anna
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Rehabiliteringsmedicin. Linköpings universitet, Hälsouniversitetet.
    Lindström, Johan
    Östergötlands Läns Landsting, Rekonstruktionscentrum, Öronkliniken US.
    Ledin, Torbjörn
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Oto-Rhino-Laryngologi. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Rekonstruktionscentrum, Öronkliniken US.
    Falkmer, Torbjörn
    Jönköping University, Jönköping Sweden.
    Performance and Autonomic Responses during Motion Sickness2009Inngår i: Human Factors, ISSN 0018-7208, E-ISSN 1547-8181, Vol. 51, nr 1, s. 56-66Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Objective: The aim of the study was to investigate how motion sickness, triggered by an optokinetic drum, affects short term memory performance and to explore autonomic responses to perceived motion sickness.

    Background: Previous research has found motion sickness to decrease performance, but it is not known how short term memory in particular is affected.

    Method: Thirty-eight healthy participants performed a listening span test while seated in a rotating optokinetic drum. Measurements of motion sickness, performance, heart rate, skin conductance, blood volume pulse, and pupil size were performed simultaneously throughout the experiment.

    Results: A total of 16 participants terminated the trial due to severe nausea, while the other 22 endured the full 25 minutes. Perceived motion sickness increased over time in both groups, but less among those who endured the trial. Short term memory performance decreased towards the end for those who terminated, while it increased for the other group. Results from the measured autonomic responses were ambiguous.

    Conclusion: The present study concludes that performance, measured as short term memory, declines as perceived motion sickness progresses.

    Application: This research has potential implications for command and control personnel in risk of developing motion sickness.

  • 84.
    Dahlman, Joakim
    et al.
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Rehabiliteringsmedicin. Linköpings universitet, Hälsouniversitetet.
    Sjörs, Anna
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Rehabiliteringsmedicin. Linköpings universitet, Hälsouniversitetet.
    Lundgren, Pontus
    Östergötlands Läns Landsting, Rekonstruktionscentrum, Rehabiliteringsmedicinska kliniken US.
    Ledin, Torbjörn
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Oto-Rhino-Laryngologi. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Rekonstruktionscentrum, Öronkliniken US.
    Falkmer, Torbjörn
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Rehabiliteringsmedicin. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Närsjukvården i centrala Östergötland, Habiliteringen: Barn- och ungdomshabiliteringen, LSS Råd och stöd.
    Effects of Motion Sickness on Encoding and Retrieval2010Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Objective: In this study, possible effects of motion sickness on encoding and retrieval of words were investigated.

    Background: The impact of motion sickness on human performance has been studied with regards to psychomotor functions and over learned skills, as well as to novel situations requiring encoding and retrieval skills through the use of short term memory. In this study, possible effects of motion sickness on encoding and retrieval of words were investigated.

    Method: Forty healthy participants, half of them males, performed a continuous recognition task (CRT) during exposure to a motion sickness triggering optokinetic drum. The CRT was employed as a measurement of performance and consisted of encoding and retrieval of words. The task consisted of three consecutive phases 1) encoding of familiar words; 2) encoding and retrieval of words under the influence of motion sickness; 3) retrieval of words after exposure.

    Results: Data analysis revealed no significant differences in the ability to encode or retrieve words during motion sickness compared with a control condition. In addition, there were no significant correlations between the level of motion sickness and performance of the CRT.

    Conclusion: The results indicate that encoding and retrieval of words are not affected by moderate levels of motion sickness. Application: This research has implications for operational settings where professionals experience moderate levels of motion sickness.

  • 85.
    Danielsson, Pär
    et al.
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för biomedicin och kirurgi, Hand och plastikkirurgi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Hand- och plastikkirurgiska kliniken US.
    Adolfsson, Lars
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för biomedicin och kirurgi, Hand och plastikkirurgi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Hand- och plastikkirurgiska kliniken US.
    Dahlin, Lars B
    Different effect on axonal outgrowth of application of non-absorbable or absorbable tubes around a nerve repair2001Inngår i: Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery, ISSN 2000-656X, E-ISSN 2000-6764, Vol. 35, nr 4, s. 347-353Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    We studied regeneration distance of rat sciatic nerve, with the sensory pinch reflex test and immunocytochemical staining for neurofilaments, four to 21 days after transsection, repair, and enclosure of the repair site in either a non-absorbable silicone tube or an absorbable polyglycolic acid (PGA) tube. The size of both tube-types was carefully selected so that they did not compress the repaired nerve. The opposite nerve was repaired and not inserted in a tube (control). The regeneration distances in repaired nerves enclosed in silicone tube were significantly longer than the control side at all time points, a result not seen when PGA tube was used. The number of proliferating non-neuronal cells (incorporation of 5-bromodeoxyuridine (BrdU)) was studied just proximal to the site of nerve repair after six days. Numerous stained cells were seen, but there where no significant differences between the groups. We conclude that outgrowth of sensory axons after transsection and repair of rat sciatic nerve with sutures can be increased by enclosing the site of repair in a silicone tube but not in a PGA tube. The effect is probably not related to the number of proliferative non-neuronal cells.

  • 86.
    Danielsson, Pär
    et al.
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Kirurgi. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Rekonstruktionscentrum, Hand- och plastikkirurgiska kliniken US.
    Fredriksson, Camilla
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Hand och plastikkirurgi. Linköpings universitet, Hälsouniversitetet.
    Huss, Fredrik
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Brännskadevård. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Rekonstruktionscentrum, Hand- och plastikkirurgiska kliniken US.
    A Novel Concept for Treating Large Necrotizing Fasciitis Wounds With Bilayer Dermal Matrix, Split-thickness Skin Grafts, and Negative Pressure Wound Therapy2009Inngår i: Wounds (King of Prussia, Pa.), ISSN 1044-7946, E-ISSN 1943-2704, Vol. 21, nr 8, s. 215-220Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Treatment of necrotizing fasciitis (NF) includes radical surgical debridement often resulting in large wounds that need to be closed with methods including split-thickness skin grafts (STSG), local flaps, or guided tissue regeneration procedures. In this case report, a 45 year-old Caucasian male was surgically treated for a benign left groin hernia, developed NF, and was transferred to the authors burn unit. The wound was treated initially with wide debridement and with a brief delay before finally closing the wound. A collagen matrix such as Integra (R) Dermal Regeneration Template (Integra LifeSciences, Plainsboro, NJ) in combination with STSG and negative pressure wound treatment, can provide fast recovery resulting in pliable, functional skin.

  • 87.
    Diczfalusy, Elin
    et al.
    Linköpings universitet, Institutionen för medicinsk teknik, Biomedicinsk instrumentteknik. Linköpings universitet, Tekniska högskolan.
    Didzar, Nil
    Östergötlands Läns Landsting, Närsjukvården i centrala Östergötland, Neurologiska kliniken.
    Kullman, Anita
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Klinisk kemi. Linköpings universitet, Hälsouniversitetet.
    Åström, Mattias
    Linköpings universitet, Institutionen för medicinsk teknik, Biomedicinsk instrumentteknik. Linköpings universitet, Tekniska högskolan.
    Zsigmond, Peter
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Neurokirurgi. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Rekonstruktionscentrum, Neurokirurgiska kliniken US.
    Wårdell, Karin
    Linköpings universitet, Institutionen för medicinsk teknik, Biomedicinsk instrumentteknik. Linköpings universitet, Tekniska högskolan.
    Biochemical monitoring and simulation of the electric field during deep brain stimulation (oral)2010Konferansepaper (Annet vitenskapelig)
  • 88.
    Diczfalusy, Elin
    et al.
    Linköpings universitet, Institutionen för medicinsk teknik, Biomedicinsk instrumentteknik. Linköpings universitet, Tekniska högskolan.
    Åström, Mattias
    Linköpings universitet, Institutionen för medicinsk teknik, Biomedicinsk instrumentteknik. Linköpings universitet, Tekniska högskolan.
    Didzar, Nil
    Östergötlands Läns Landsting, Närsjukvården i centrala Östergötland, Neurologiska kliniken.
    Kullman, Anita
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Klinisk kemi. Linköpings universitet, Hälsouniversitetet.
    Zsigmond, Peter
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Neurokirurgi. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Rekonstruktionscentrum, Neurokirurgiska kliniken US.
    Wårdell, Karin
    Linköpings universitet, Institutionen för medicinsk teknik, Biomedicinsk instrumentteknik. Linköpings universitet, Tekniska högskolan.
    A finite element model for biochemical monitoring in the brain during deep brain stimulation (poster)2010Konferansepaper (Fagfellevurdert)
  • 89.
    Diczfalusy, Elin
    et al.
    Linköpings universitet, Institutionen för medicinsk teknik, Biomedicinsk instrumentteknik. Linköpings universitet, Tekniska högskolan.
    Åström, Mattias
    Linköpings universitet, Institutionen för medicinsk teknik, Biomedicinsk instrumentteknik. Linköpings universitet, Tekniska högskolan.
    Dizdar, Nil
    Östergötlands Läns Landsting, Närsjukvården i centrala Östergötland, Neurologiska kliniken. Östergötlands Läns Landsting, Rekonstruktionscentrum, Neurokirurgiska kliniken US.
    Kullman, Anita
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Klinisk kemi. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Rekonstruktionscentrum, Neurokirurgiska kliniken US.
    Zsigmond, Peter
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Neurokirurgi. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Rekonstruktionscentrum, Neurokirurgiska kliniken US.
    Wårdell, Karin
    Linköpings universitet, Institutionen för medicinsk teknik, Biomedicinsk instrumentteknik. Linköpings universitet, Tekniska högskolan.
    A Finite Model for Biochemical Monitoring in the Brain during Deep Brain Stimulation (oral)2010Konferansepaper (Fagfellevurdert)
  • 90.
    Djerf, Emelie
    et al.
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Onkologi. Linköpings universitet, Hälsouniversitetet.
    Trinks, Cecilia
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Onkologi. Linköpings universitet, Hälsouniversitetet.
    Abdiu, Avni
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Kirurgi. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Rekonstruktionscentrum, Hand- och plastikkirurgiska kliniken US.
    Thunell, Lena
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Cellbiologi. Linköpings universitet, Hälsouniversitetet.
    Hallbeck, Anna-Lotta
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Onkologi. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Kirurgi- och onkologicentrum, Onkologiska kliniken US.
    Walz, Thomas M
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Onkologi. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Kirurgi- och onkologicentrum, Onkologiska kliniken US.
    ErbB receptor tyrosine kinases contribute to proliferation of malignant melanoma cells: inhibition by gefitinib (ZD1839)2009Inngår i: Melanoma research, ISSN 0960-8931, E-ISSN 1473-5636, ISSN 0960-8931, Vol. 19, nr 3, s. 156-166Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Members of the epidermal growth factor (EGF) family of structurally related tyrosine kinase receptors, known as the ErbB receptors (EGFR/ErbB1/HER1, ErbB2/HER2/neu, ErbB3/HER3 and ErbB4/HER4) and their respective ligands, have been suggested to be involved in the development and progression of malignant melanoma. Here we investigate the effects of the ErbB1 tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) on human malignant melanoma cells (RaH3 and RaH5) in vitro. ZD1839 inhibited proliferation of exponentially growing RaH3 and RaH5 cells in a dose-dependent manner with a half-maximally effective dose of 3.5 and 2.0 mu mol/l, respectively. Cell growth was inhibited at 0.1 mu mol/l ZD1839 in both cell lines. Maximal inhibition was accomplished at 10 mu mol/l ZD1839; however, the effect was not complete as both cell lines showed a continuous slow growth during the treatment period. Flow cytometry analysis of cell-cycle distribution showed that ZD1839 treatment caused accumulation of RaH3 and RaH5 cells in the G, phase. The growth arrest induced by ZD1839 coincided with upregulation of the cyclin-dependent kinase inhibitor p27(KIP1). There was no increase in apoptosis as determined by analysis of plasma phosphatidyl serine redistribution. Western blot analysis revealed that ZD1839 substantially reduced tyrosine phosphorylation of ErbB1 as well as ErbB2 and ErbB3. This was accompanied by a concomitant decrease in Akt-phosphorylation, Erk1/2-phosphorylation, and Stat3-phosphorylation. Our results show that ZD1839 interferes with the growth of human malignant melanoma cells by cytostatic effects. These findings indicate the possible use of ErbB receptor kinase inhibitors as a novel treatment strategy in malignant melanoma.

  • 91.
    Droog Tesselaar, Erik
    et al.
    Linköpings universitet, Institutionen för medicinsk teknik. Linköpings universitet, Hälsouniversitetet.
    Henricson, Joakim
    Linköpings universitet, Institutionen för klinisk och experimentell medicin. Linköpings universitet, Hälsouniversitetet.
    Nilsson, Gert E.
    Linköpings universitet, Institutionen för medicinsk teknik, Biomedicinsk instrumentteknik. Linköpings universitet, Tekniska högskolan.
    Sjöberg, Folke
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Brännskadevård. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Rekonstruktionscentrum, Hand- och plastikkirurgiska kliniken US.
    A protocol for iontophoresis of acetylcholine and sodium nitroprusside that minimises nonspecific vasodilatory effects2004Inngår i: Microvascular research, ISSN 0026-2862, Vol. 67, nr 2, s. 197-202Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Iontophoresis of vasoactive substances is a promising tool for studying pharmacological aspects of the (patho)physiology of the microvasculature. However, nonspecific microvascular responses are a common problem in most protocols used. We studied the effect of current density (mA/cm2), charge density (mC/cm2), drug concentration (mass %) and vehicle concentration (M) on the nonspecific vasodilatation during iontophoresis of sodium chloride, acetylcholine (ACh) and sodium nitroprusside (SNP).

    We found that nonspecific vasodilatation depended on current density and charge density in both anodal and cathodal iontophoresis. The responses to ACh and SNP were dependent on current density, charge density and drug concentration. We found that by limiting current density (<0.01 mA/cm2) and charge density (<7.8 mC/cm2) and with adjusted concentrations for drugs and vehicles, it is possible to prevent nonspecific effects during iontophoresis of ACh and SNP, while maximum drug effects (plateaus in the dose–response curves) are still obtained. These new findings are important for future iontophoresis studies in which vasoactive drugs are used to assess microvascular function because the presented approach has advantages compared to older techniques, which mainly have attempted to suppress or compensate for the nonspecific responses during iontophoresis by the use of local anaesthetics or the measurement of drug-minus-vehicle responses, both of which present well-known experimental shortcomings.

  • 92.
    Edell-Gustafsson, Ulla
    et al.
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för medicin och vård, Omvårdnad.
    Carstensen, John
    Linköpings universitet, Filosofiska fakulteten. Linköpings universitet, Institutionen för hälsa och samhälle, Tema hälsa och samhälle.
    Regestein, Quentin
    Swahn, Eva
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för medicin och vård, Kardiologi. Östergötlands Läns Landsting, Hjärtcentrum, Kardiologiska kliniken.
    Svanborg, Eva
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Klinisk Neurofysiologi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Neurofysiologiska kliniken US.
    Hyperarousal, depression and quality of life - Validity and reliability of the Swedish version of the Hyperarousal Scale2006Inngår i: Scandinavian Journal of Caring Sciences, ISSN 0283-9318, E-ISSN 1471-6712, Vol. 20, nr 1, s. 58-67Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Aim: Research focusing on hyperarousability in association with general sensitivity to stress has increased. This study aimed to: (i) describe values for self-reported hyperarousal behaviour traits, depression, sleeplessness behaviour and health-related quality of life [The Short Form 36 Health Survey Questionnaire (SF-36)] in a gender-stratified random sample from the Swedish population, and (ii) test the validity and reliability of the Swedish version of the Hyperarousal Behavioural Trait Scale (H-scale). Methods: In this study, 402 women and 391 men from Sweden were included. A test-retest study was performed on 297 subjects. Results: The total mean score on the H-scale was 29.5 (SD 10.0, 95% CI 28.8-30.2). Compared to men, women scored higher on the H-scale (total score, sub-scales and many items), whereas no evidence of an age trend was seen. The H-scale has proven to be a valid and reliable scale. Pearson's correlation coefficient showed similar magnitude and direction between the H-scale and the Zung's Self-rating Depression Scale, as between the H-scale and the Vicious Cycle of Sleeplessness Behaviour Scale, Vitality, Mental Health and the Mental Component Summary index on the SF-36 respectively. The Cronbach's alpha for the H-scale was 0.84 and estimated stability test-retest point of time varies between 0.73 and 0.80. Conclusions: This study indicates gender differences in response style in association with altered health-related quality of life. The H-scale is a valid and reliable self-reported scale for measuring hyperarousal behavioural trait research outcome in clinical practice. © 2006 Nordic College of Caring Science.

  • 93.
    Edell-Gustafsson, Ulla
    et al.
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för medicin och vård, Omvårdnad.
    Svanborg, Eva
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Klinisk Neurofysiologi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Neurofysiologiska kliniken US.
    Swahn, Eva
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för medicin och vård, Kardiologi. Östergötlands Läns Landsting, Hjärtcentrum, Kardiologiska kliniken.
    A gender perspective on sleeplessness behavior, effects of sleep loss, and coping resources in patients with stable coronary artery disease2006Inngår i: Heart & Lung, ISSN 0147-9563, E-ISSN 1527-3288, Vol. 35, nr 2, s. 75-89Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    OBJECTIVE: The primary aim of this study was to systematically compare perceived sleep quality, sleeplessness behavior, sense of mastery, self-esteem, depression, subjective health, and effects of sleep loss in men and women with stable coronary artery disease (CAD). Further aims were to determine possible predictors of poor sleep quality and sense of mastery, as well as the consequences of too little sleep. METHODS: Comparative-correlation and predictive design were used. Patients with a history of stable angina pectoris scheduled to undergo coronary angiography at Linköping University Hospital in Sweden were included. There were 47 women and 88 men (mean age 62.4 years) with CAD. Structured interviews using validated questionnaires covered sleep quality and sleep habits, effects of sleep loss, psychologic resources, and depression. RESULTS: Multiple stepwise regression analysis showed that sleeplessness behavior, depressed mood, female gender, and pharmacologic treatments with inflammation inhibitors significantly (P < .0001) accounted for the variance of poorer sleep quality. The analysis also showed that the following factors in descending order significantly accounted (P < .0001) for the outcome of sleep quality: inability to feel refreshed by sleep, difficulty in maintaining sleep, gastrointestinal problems, too little sleep, final morning awakening time, sleep onset latency, lying down because of daytime tiredness, and daytime physical tiredness. CONCLUSIONS: Compared with men, women with stable CAD may be especially at risk of experiencing poor sleep quality, even when sleeplessness behavior and pharmacologic treatments with inflammation inhibitors are controlled. It is also possible that they may be more at risk of depressed mood. Copyright © 2006 by Mosby, Inc.

  • 94.
    Edell-Gustafsson, Ulla
    et al.
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för medicin och vård, Omvårdnad.
    Svanborg, Eva
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Klinisk Neurofysiologi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Neurofysiologiska kliniken US.
    Swahn, Eva
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för medicin och vård, Kardiologi. Östergötlands Läns Landsting, Hjärtcentrum, Kardiologiska kliniken.
    Psychological behavioural symptoms and sleep quality in patients with stable coronary artery disease2004Inngår i: Congress of the European Sleep Research Society,2004, 2004, s. 207-207Konferansepaper (Annet vitenskapelig)
  • 95.
    Edell-Gustafsson, Ulla
    et al.
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för medicin och vård, Omvårdnad.
    Swahn, Eva
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för medicin och vård, Kardiologi. Östergötlands Läns Landsting, Hjärtcentrum, Kardiologiska kliniken.
    Svanborg, Eva
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Klinisk Neurofysiologi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Neurofysiologiska kliniken US.
    Hyperarousal behavioural trait, sufficient sleep index and health related qualtiy of life insomnia associated professional sleep societies (APSS)2005Inngår i: Associated Professional Sleep Societies APSS,2005, 2005Konferansepaper (Annet vitenskapelig)
  • 96.
    Eden, U
    et al.
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Oftalmologi. Linköpings universitet, Hälsouniversitetet.
    Lagali, Neil
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Oftalmologi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Ögonkliniken US/LiM. Linköpings universitet, Hälsouniversitetet.
    Fagerholm, Per
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Oftalmologi. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Rekonstruktionscentrum, Ögonkliniken US/LiM.
    Pathologic epithelial and anterior corneal nerve morphology in congenital aniridic keratopathy in ACTA OPHTHALMOLOGICA, vol 88, issue , pp 52-522010Inngår i: ACTA OPHTHALMOLOGICA, Blackwell Publishing Ltd , 2010, Vol. 88, s. 52-52Konferansepaper (Fagfellevurdert)
    Abstract [en]

    n/a

  • 97.
    Engman, Maria
    et al.
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Genus och medicin. Linköpings universitet, Hälsouniversitetet.
    Lindehammar, Hans
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Klinisk neurofysiologi. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Rekonstruktionscentrum, Neurofysiologiska kliniken US.
    Wijma, Barbro
    Linköpings universitet, Institutionen för klinisk och experimentell medicin, Genus och medicin. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Barn- och kvinnocentrum, Kvinnokliniken i Linköping.
    Surface electromyography diagnostics in women with partial vaginismus with or without vulvar vestibulitis and in asymptomatic women2004Inngår i: Journal of Psychosomatic Obstetrics & Gynecology, ISSN 0167-482X, Vol. 25, nr 3/4, s. 281-294Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    The aim of this study was to investigate to what extent women with superficial dyspareunia can be diagnosed for both partial vaginismus (PaV) and vulvar vestibulitis (VVS) and to discover to what extent surface electromyography (sEMG) of the pelvic floor muscles (PFM) can distinguish between women with PaV solely, PaV + VVS, and asymptomatic women. A total of 224 consecutive women with superficial dyspareunia were examined clinically for both PaV and VVS diagnoses. We examined 47 women with PaV ± VVS and 27 asymptomatic women with sEMG of the PFM. The results showed that 102/224 women with superficial dyspareunia and 33/47 women with PaV in the sEMG part of the study had both PaV and VVS. All women with VVS had vaginismus, while 42/224 had PaV but not VVS. sEMG measurements revealed no significant differences between the three groups of women (PaV solely, PaV + VVS, and asymptomatic). Almost half of the women with superficial dyspareunia referred to our clinic have both the diagnosis PaV and VVS. sEMG was not a method of any value to distinguish between women with PaV solely, PaV + VVS, or asymptomatic women. The increased tone found clinically in the PFM of women with PaV ± VVS may be of other origin than electrogenic contractions.

  • 98. Engquist, Bo
    et al.
    Åstrand, Per
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Käkkirurgi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Käkkliniken US.
    Anzén, Bengt
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Käkkirurgi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Käkkliniken US.
    Dahlgren, Simon
    Engquist, Eva
    Feldmann, Hartmut
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Käkkirurgi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Käkkliniken US.
    Karlsson, Ulf
    Nord, Per Gunnar
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Käkkirurgi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Käkkliniken US.
    Sahlholm, Sten
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Käkkirurgi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Käkkliniken US.
    Svärdström, Pia
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Käkkirurgi. Östergötlands Läns Landsting, Rekonstruktionscentrum, Käkkliniken US.
    Simplified methods of implant treatment in the edentulous lower jaw. A controlled prospective study. Part I: one-stage versus two-stage surgery.2002Inngår i: Clinical Implant Dentistry and Related Research, ISSN 1523-0899, E-ISSN 1708-8208, Vol. 4, nr 2, s. 93-103Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    BACKGROUND: The original protocol for Brσnemark System implants in the mandible was a two-stage procedure with 3 months healing time. With five or six implants and a cast framework of gold, the treatment is rather expensive, and simplified methods would be desirable. PURPOSE: The goal of this controlled serial study was to investigate the outcome of a simplified procedure with one-stage surgery, four Brσnemark implants, shortened healing time, and a new titanium-acrylic fixed full prosthesis. MATERIALS AND METHODS: Eighty-two patients were treated in three different groups at two specialist centers. All patients were provided with four implants, loaded with a Procera All-in-One bridge (Nobel Biocare, Gothenburg, Sweden) after 12 weeks. In group A (n = 30), one-stage surgery was combined with two-piece implants. In group B (n = 30), the control group, two-stage surgery and two-piece implants were used. In group C (n = 22), one-stage surgery was combined with one-piece implants. Marginal bone level was rated from radiographs at implant insertion, at baseline, and after 1 year. RESULTS: The survival rate after 1 year for group A was 93.3%, group B, 97.5%, and group C, 93.2%. The differences were not statistically significant. Between fixture insertion and baseline, the average bone loss for group A was 1.2 mm, group B, 1.3 mm, and group C, 1.3 mm. No complications in the form of bridge loosening or acrylic fractures were recorded during the first year. CONCLUSIONS: The survival rates and the marginal bone changes did not differ significantly between the one-stage groups and the control group. The survival rate and the marginal bone changes were similar for one-piece and two-piece implants. Four implants were sufficient to support full fixed prostheses in the mandibles. The Procera All-in-One bridges proved to be of high quality, and no complications were experienced. key words: endosseous implants, nonsubmerged implants, one-piece implants, prospective clinical study, submerged implants

  • 99. Engquist, Bo
    et al.
    Åstrand, Per
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Käkkliniken.
    Anzén, Bengt
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Käkkliniken. Östergötlands Läns Landsting, Rekonstruktionscentrum, Käkkliniken US.
    Dahlgren, Simon
    Engquist, Eva
    Feldmann, Hartmut
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Käkkliniken.
    Karlsson, Ulf
    Nord, Per Gunnar
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Käkkliniken. Östergötlands Läns Landsting, Rekonstruktionscentrum, Käkkliniken US.
    Sahlholm, Sten
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Käkkliniken. Östergötlands Läns Landsting, Rekonstruktionscentrum, Käkkliniken US.
    Svärdström, Pia
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Käkkliniken. Östergötlands Läns Landsting, Rekonstruktionscentrum, Käkkliniken US.
    Simplified methods of implant treatment in the edentulous lower jaw. Part II: Early loading2004Inngår i: Clinical Implant Dentistry and Related Research, ISSN 1523-0899, E-ISSN 1708-8208, Vol. 6, nr 2, s. 90-100Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Background: Most implant treatment is performed with a two-stage surgical procedure. A disadvantage of these implant treatments is that they are time-consuming. Purpose: The aim of the present study was to evaluate the results of early loading in the edentulous mandible and to compare those results with treatment results of one-stage surgery followed by a healing period and with two-stage surgery. Material and Methods: The material comprises four treatment groups with a total of 108 patients with edentulous lower jaws and 432 implants. All patients were treated with Brånemark implants (Nobel Biocare AB, Gothenburg, Sweden) with a turned surface and fixed prostheses in the lower jaw, supported by four implants. The patients in group A were treated with a one-stage procedure, a two-piece implant, and a 3-month healing period before loading. Group B (control group) had a two-stage procedure, a two-piece implant, and a 3-month healing period. Group C had a one-stage procedure, a one-piece implant, and a 3-month healing period. Group D was treated with a one-stage surgical procedure, a two-piece implant, and early loading (within 3 weeks). All patients were provided with a Procera® Implant Bridge (Nobel Biocare) with a framework made by computer-assisted milling of one piece of pure titanium. All patients have been followed up for 1 year. Results: The survival rates were 93.2 to 93.3% in the experimental groups and 97.5% in the control group. The difference was not statistically significant. The measurements of the marginal bone level demonstrated a mean bone loss of 0.8 mm between fixture insertion and the 1-year examination in patients with early loading (group D) whereas the bone loss in patients who underwent a healing period before loading was 1.3 to 1.6 mm. The difference between the control group and the group with early loading was significant. Conclusions: Survival rates for patients treated with a one-stage procedure were lower than survival rates for patients treated according to a "classical concept," but the differences were not statistically significant. There was no difference between treatment results with one-piece and two-piece implants. The implant loss in patients with early loading was probably caused by overloading, and careful supervision of occlusal loading is recommended. Early loading gave significantly less marginal bone loss when compared with two-stage surgery.

  • 100. Engquist, Bo
    et al.
    Åstrand, Per
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Käkkliniken.
    Anzén, Bengt
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Käkkliniken. Östergötlands Läns Landsting, Rekonstruktionscentrum, Käkkliniken US.
    Engquist, Eva
    Feldmann, Hartmut
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Käkkliniken.
    Nord, Per Gunnar
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Käkkliniken. Östergötlands Läns Landsting, Rekonstruktionscentrum, Käkkliniken US.
    Sahlholm, Sten
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Käkkliniken. Östergötlands Läns Landsting, Rekonstruktionscentrum, Käkkliniken US.
    Svärdström, Pia
    Linköpings universitet, Hälsouniversitetet. Linköpings universitet, Institutionen för nervsystem och rörelseorgan, Käkkliniken. Östergötlands Läns Landsting, Rekonstruktionscentrum, Käkkliniken US.
    Simplified methods of implant treatment in the edentulous lower jaw: A 3-year follow-up report of a controlled prospective study of one-stage versus two-stage surgery and early loading2005Inngår i: Clinical Implant Dentistry and Related Research, ISSN 1523-0899, E-ISSN 1708-8208, Vol. 7, nr 2, s. 95-104Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Background: Interest in the use of one-stage surgery and immediate loading of oral implants has lately been increasing. Purpose: The aim of this study was to compare the 3-year results of one-stage surgery versus two-stage surgery, early loading versus loading after a 3-month healing period, and the use of one-piece implants versus the use of two-piece implants. Materials and Methods: The study included 108 patients with edentulous mandibles. Each patient was treated with four Brånemark System® implants (Nobel Biocare AB, Göteborg, Sweden) and with full fixed prostheses. Patients were consecutively treated and were distributed in four groups: group A (one-stage surgery), group B (control group with two-stage surgery), group C (one-piece implants), and group D (early loading). In groups A and B Brånemark Standard implants and standard abutments were used. In group C the conical one-piece Brånemark implant was used, and in group D the patients had Brånemark System Mk III implants together with multiunit abutments. All patients were observed for 3 years. Results: Of the 432 inserted implants, 24 were lost. Survival rates in the three experimental groups ranged from 93.2 to 93.3% whereas the survival rate in group B (the control group with two-stage surgery) was 97.5%. The differences between the groups were not statistically significant. The changes in marginal bone level were measured from fixture insertion to the final follow-up at 3 years. The bone loss in group D (early loading) was significantly less than in group B (the control group) whereas there were no differences in marginal bone change between the other groups. Conclusions: Early loading seemed to give good results in the anterior part of the mandible. The survival rate of the early-loaded implants did not significantly differ from that of implants inserted with the conventional two-stage procedure, but the mean marginal bone loss around the surviving implants was less with early loading. ©2005 BC Decker Inc.

1234567 51 - 100 of 654
RefereraExporteraLink til resultatlisten
Permanent link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf